Precision Diabetes
Business Services · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2474 Walnut St PMB 168, Cary, North Caro...Phone Number
(919) 390-1391Website
www.precisiondiabetesinc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
2
1
1
1
About Precision Diabetes
Precision Diabetes Inc. is an emerging leader in precision medicine for diabetes, specializing in novel biomarkers and algorithms. The company is the exclusive supplier of the GlycoMark test, which is FDA-cleared and CE-Marked for detecting recent hyperglycemia and glycemic variability across multiple regions including the U.S. and Europe. Their product portfolio also includes partnerships for distributing genetic tests for type 2 diabetes and gestational diabetes. Precision Diabetes aims to revolutionize diabetes diagnostics by offering a range of unique tests that assess the risk and complications associated with diabetes.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Precision Diabetes your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Precision Diabetes had a recent Job posting/layoffs
Product Launch: Get notified when Precision Diabetes launches new products
Congratulate Masked Content for being promoted to Masked Content at Precision Diabetes
Earning: See what the market has to say on Precision Diabetes recently announced quarterly report
Check out if Precision Diabetes is spiking on competitors!
Precision Diabetes, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Precision Diabetes has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Precision Diabetes has new funding data
Recommended Actions
Find VP level buyers at Precision Diabetes
Find 2 more new buyers
Compare Similar Companies to Precision Diabetes
Compare insights from companies similar to Precision Diabetes, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Precision Diabetes
<$5M
11-50
Private
-
2020
N/A
Company Profile Activity
Activity Insights
Precision Diabetes is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Precision Diabetes is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Precision Diabetes.
Precision Diabetes Tech Stack
A closer look at the technologies used by Precision Diabetes
See more technologies
Precision Diabetes News & Media
Precision Diabetes and Nagase Diagnostics Announce Exclusive U.S. Commercialization Partnership for Lucica® Glycated Albumin-L, the Only FDA-Cleared Assay Specifically Measured Glycated Albumin in the United States
Partnership expands access to an useful intermediate-term glycemic biomarker that complements HbA1c *1,2*and Continuous Glucose Monitoring 3 while providing additional insights into glycemic status to support diabetes management. RALEIGH, N.C. and ITASCA, Ill., July 23, 2026 /PRNewswire/...Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial
New analysis supports DNlite™ for earlier renal risk stratification in patients with type 2 diabetes and chronic kidney disease ZHUBEI CITY, Taiwan and RALEIGH, N.C., June 5, 2026 /PRNewswire/ -- Bio Preventive Medicine Corp. and Precision Diabetes, Inc. today announced presentation of a...A New Study Shows GlycoMark is a Novel Biomarker of SGLT-2i Adherence
RALEIGH, N.C., Jan. 10, 2024 /PRNewswire/ -- A new study, "1,5-Anhydroglucitol: A Novel Biomarker of Adherence in Sodium -Glucose Cotransporter 2 Inhibitors," was published online on December 13, 2023, in Diabetes Care, a journal from the American Diabetes Association. The study was...New Clinical Data Point to Use of GlycoMark as Biomarker of SGLT-2 Diabetes Drug Effectiveness and Compliance
RALEIGH, N.C., Oct. 30, 2023 /PRNewswire/ -- Precision Diabetes, Inc. announces new studies that show that the GlycoMark blood test, which measures 1,5-anhydroglucitol, may be useful for evaluating short-term effectiveness and assessing patient compliance of SGLT-2 inhibitor diabetes...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Precision Diabetes
Sign Up For FreeTo access detailed company insights
Precision Diabetes Inc. is an emerging leader in precision medicine for diabetes, specializing in novel biomarkers and algorithms. The company is the exclusive supplier of the GlycoMark test, which is FDA-cleared and CE-Marked for detecting recent hyperglycemia and glycemic variability across multiple regions including the U.S. and Europe. Their pr... Read More
